Profil
Robert Edward Sosnowski founded Dexgen Pharmaceuticals, Inc. in 2000, where he worked as President & Chief Executive Officer.
Mr. Sosnowski also formerly worked at Algos Pharmaceutical Corp., as Vice President-Sales & Marketing and Cyclacel Pharmaceuticals, Inc., as Vice President-Sales & Marketing in 2012.
Mr. Sosnowski received his undergraduate degree in 1980 from the University of Connecticut.
Anciens postes connus de Robert Sosnowski
| Sociétés | Poste | Fin |
|---|---|---|
| CYCLACEL PHARMACEUTICALS, INC. | Sales & Marketing | 30/06/2012 |
Algos Pharmaceutical Corp.
 Algos Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Part of Endo International Plc, Algos Pharmaceutical Corp. develops and makes pain management products including narcotic drugs. The company is based in Neptune, NJ. Algos Pharmaceutical was acquired by Endo Health Solutions, Inc. on July 17, 2000 for $243.89 million. | Sales & Marketing | - |
| Dexgen Pharmaceuticals, Inc. | Fondateur | - |
Formation de Robert Sosnowski
| University of Connecticut | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Algos Pharmaceutical Corp.
Algos Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Part of Endo International Plc, Algos Pharmaceutical Corp. develops and makes pain management products including narcotic drugs. The company is based in Neptune, NJ. Algos Pharmaceutical was acquired by Endo Health Solutions, Inc. on July 17, 2000 for $243.89 million. | Health Technology |
| Dexgen Pharmaceuticals, Inc. |